Review
World J Hematol
2(3):62-70.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.62
Abstract (2582)
|
Core Tip (1860)
|
Full Article (HTML) (53499)
|
Figures (1-9) (1313)
|
Full Article (PDF)-576K (2493)
|
Peer-Review Report-178K (473)
|
Answering Reviewers-107K (447)
|
Received: 04/01/2013
|
Revised: 05/14/2013
|
Accepted: 06/10/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (11)
|
Total Visits (67087)
|
Similar Articles (16)
|
Timeline of Article Publication (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
PVSG and WHO vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms

World J Hematol
2(3):71-88.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.71
Abstract (1938)
|
Core Tip (1649)
|
Full Article (HTML) (10056)
|
Figures (1-10) (589)
|
Tables (1-6) (492)
|
Full Article (PDF)-3685K (962)
|
Peer-Review Report-98K (450)
|
Answering Reviewers-50K (366)
|
Received: 01/11/2013
|
Accepted: 06/18/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (19748)
|
Similar Articles (5)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hematol
2(3):89-98.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.89
Abstract (1909)
|
Core Tip (1598)
|
Full Article (HTML) (8431)
|
Figures (1-6) (556)
|
Tables (1-2) (357)
|
Full Article (PDF)-1438K (770)
|
Peer-Review Report-192K (280)
|
Answering Reviewers-63K (289)
|
Received: 03/11/2013
|
Revised: 05/10/2013
|
Accepted: 06/06/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (17512)
|
Similar Articles (34)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open